title: Diversity and prevalence of somatic mutations in the thyrotropin receptor and Gs alpha genes as a cause of toxic thyroid adenomas.
abstract: A total of 33 different autonomous hot nodules from 31 patients, originating mainly from Belgium, were investigated for the presence of somatic mutations in the TSH receptor and Gs alpha genes. This constitutes an extension of our previous study, including the first 11 nodules of the series. The complete coding sequence of the TSH receptor gene and the segments of Gs alpha known to harbor mutations impairing guanosinetriphosphotase activity were studied by direct sequencing of genomic DNA extracted from the nodules. DNA from the juxtanodular tissue or peripheral white blood cells was analyzed in all patients to confirm that the mutations identified were somatic. Twenty-seven mutations (82%) were found in the TSH receptor gene, affecting a total of 12 different residues or locations. All these mutations but 2 (see below) have been identified previously as activating mutations. Only 2 mutations were found in Gs alpha (6%). In 4 nodules, no mutation was detected. Five residues (Ser281, Ile486, Ile568, Phe631, and Asp633) were found mutated in 3 or 4 different nodules, making them hot spots for activating mutations. Phe631 and Asp633 belong to a cluster of 5 consecutive residues (629-633) in the N-terminal half of transmembrane segment VI; which harbor together 44% of the mutations identified in this cohort. Two novel mutations were identified: a point mutation causing substitution of Phe for Leu at position 629 (L629F); and a deletion of 12 bases removing residues 658-661 at the C-terminal portion of exoloop 3 (del658-661). When tested by transfection in COS-7 cells, both mutant receptors display increase in constitutive stimulation of basal cAMP accumulation. Although it is still capable of binding TSH, the del658-661 mutant has completely lost the ability to respond to the stimulation by the hormone. Our results demonstrate that, in a cohort of patients from a moderately iodine deficient area, somatic mutations increasing the constitutive activity of the TSH receptor are the major cause of autonomous hot nodules.
authors.affiliation: Department of Medical Genetics, Université Libre de Bruxelles, Belgium.
authors.forename: J
authors.initials: J
authors.lastname: Parma
authors.forename: L
authors.initials: L
authors.lastname: Duprez
authors.forename: J
authors.initials: J
authors.lastname: Van Sande
authors.forename: J
authors.initials: J
authors.lastname: Hermans
authors.forename: P
authors.initials: P
authors.lastname: Rocmans
authors.forename: G
authors.initials: G
authors.lastname: Van Vliet
authors.forename: S
authors.initials: S
authors.lastname: Costagliola
authors.forename: P
authors.initials: P
authors.lastname: Rodien
authors.forename: J E
authors.initials: JE
authors.lastname: Dumont
authors.forename: G
authors.initials: G
authors.lastname: Vassart
mesh_terms: D000236:Adenoma / Q000235:genetics*; D000328:Adult; D000368:Aged; D000595:Amino Acid Sequence; D000818:Animals; D001483:Base Sequence; D001530:Belgium; D019556:COS Cells; D000242:Cyclic AMP / Q000378:metabolism; D004252:DNA Mutational Analysis; D005260:Female; D019205:GTP-Binding Protein alpha Subunits, Gs / Q000235:genetics*; D017353:Gene Deletion; D006801:Humans; D007295:Inositol Phosphates / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D009154:Mutation; D011989:Receptors, Thyrotropin / Q000235:genetics*; D013964:Thyroid Neoplasms / Q000235:genetics*; D013972:Thyrotropin / Q000494:pharmacology; D014162:Transfection
chemical_list: D007295:Inositol Phosphates; D011989:Receptors, Thyrotropin; D013972:Thyrotropin; D000242:Cyclic AMP; D019205:GTP-Binding Protein alpha Subunits, Gs